IT is rituximab: In the USA we use what the FDA approved and that is Rituxan (rituximab) and in Europe the name Mabthera is what was approved in Europe by their FDA the EMEA.. This medication is used for certain cancers, rheumatoid arthritis,certain inflammatory blood vessel syndromes we call vasculitiis
Answered 5/9/2015
3.5k views
Mabthera: For cancers that have too much B cells, such as non-hodgkins lymphoma & chronic lymphocytic leukemia.
Answered 5/9/2015
2.9k views
A doctor has provided 1 answer
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question